Argen X SE EBIT margin
Mi az Argen X SE EBIT margin?
A EBIT margin az Argen X SE - -281.91%
Mi a EBIT margin meghatározása?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin a Health Care szektor a NASDAQ-on cégekben a Argen X SE -hoz képest
Mit csinál Argen X SE?
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
ebit margin -hoz hasonló cégek Argen X SE
- Killi nak EBIT margin -285.43% van
- Alector nak EBIT margin -285.24% van
- Phoenix Global Resources Plc nak EBIT margin -284.08% van
- Onxeo SA nak EBIT margin -282.21% van
- Atara Biotherapeutics Inc nak EBIT margin -282.18% van
- XL Fleet Corp nak EBIT margin -281.94% van
- Argen X SE nak EBIT margin -281.91% van
- PowerHouse plc nak EBIT margin -281.73% van
- DQ Entertainment (International) nak EBIT margin -281.18% van
- DQ Entertainment (International) nak EBIT margin -281.18% van
- Kisses from Italy nak EBIT margin -279.60% van
- Cymabay Therapeutics Inc nak EBIT margin -278.14% van
- Marker Therapeutics nak EBIT margin -278.12% van